Logo
Login
$PRLD
$3.88 +$0.18 (4.86%) Close

$PRLD 4/A SEC Filings

Filed On Filing
30 Sep 2020 Form 4/A: Orbimed Advisors Llc, Director and 1 other

Acquired 3,681,822 Series B Preferred Stock (Open Market Purchase) · Acquired 1,033,084 Series C Preferred Stock (Open Market Purchase)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans